Clinical Trials · NCT06541509
Mechanisms of Semaglutide Therapy in Heart Failure Patients
- Phase
- Phase 1/Phase 2
- Recruitment status
- Unknown
- Sponsor
- University Medical Centre Ljubljana
- Enrollment
- 10
- Start date
- Jul 2024
- Locations
- 3 sites, United States, Slovenia
- Primary endpoint
- Interleukin-6 (IL-6)